Spotlight On

RSV

More in RSV

Which High-Risk Patients Should Get the RSV Vaccine?

While all adults age 75 and up are eligible, here's who's considered high risk in the 60-74 group

Nov 11, 2024
A computer rendering of a syringe and a vial of RSV vaccine.
Real-World Data on the RSV Vaccine for Older Adults

"Remarkable" how closely effectiveness in real-world setting matches clinical trial efficacy

Nov 11, 2024
A computer rendering of respiratory syncytial virus particles.

1.00 CME Credits
Improving Transitions of Care and Long-Term Outcomes for Patients With Spinal Muscular Atrophy (SMA)

0.50 CME Credits
Developing Patient-Centered Approaches to Optimize the Management of Bipolar I Disorder

2.00 CME Credits
Appropriate Healthcare Interventions in Elder, Child, and Intimate Partner Abuse

3.00 CME Credits
Pain Management and the 2022 CDC Guideline for Prescribing Opioids for Pain

1.00 CME Credits
Engaging Older Adults in Vaccine Education: A Toolkit for Healthcare Providers

0.50 CME Credits
Integrating Biomarkers and Guideline-Aligned Treatment Approaches Into Evidence-Based Care for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

1.00 CME Credits
Uncomplicated Urinary Tract Infections: Leveraging Real-World Insights to Improve Patient Care

0.25 CME Credits
Utilizing Biomarkers and Prognostic Factors to Identify Rheumatoid Arthritis Patients at Risk for Poor Outcomes